UG3CA290454

Chimeric RNA driven neopeptide vaccine for prevention of breast cancer in germline BRCA1/2 carriers

MD Anderson Cancer Center, University of Houston

PI: Isabelle Bedrosian, MPI: Anjana Bhardwaj, MPI: Preethi Gunaratne

UG3CA290300

Immunosurveillance of breast glands with oncogenic germline mutations

Massachusetts General Hospital

PI: Shadmehr Demehri

UG3CA290443

Investigating novel targets for topical immunoprevention of keratinocytic skin cancer

University Of Arizona

PI: Sally E. Dickinson, MPI: Clara Curiel-Lewandrowski

UG3CA290517

Immune determinants modulating cancer development in Lynch Syndrome

Icahn School of Medicine at Mount Sinai

PI: Nina Bhardwaj, MPI: Aimee Lucas, MPI: Robert Samstein

UG3CA301294

Engineered probiotic bacteria for colorectal cancer immunoprevention and interception

Columbia University Health Sciences

PI: Nicholas Arpaia, MPI: Tal Danino

UG3CA290302

Targeting microbial triggers of gammopathy for immunoprevention

Fred Hutchinson Cancer Center

PI: Madhav Dhodapkar, MPI: Richard Flavell, MPI: Noah Palm

UG3CA290305

Developing a novel agonist of CD137 for cancer immunoprevention

University of Missouri - Columbia

PI: Haval Shirwan, MPI: Esma Yolcu

UG3CA290468

Preclinical studies for the immunoprevention of multiple myeloma

Mayo Clinic Arizona

PI: Peter Leif Bergsagel, MPI: Marta Chesi